C. Vizdiklar Et Al. , "Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study," Vascular Pharmacology , vol.156, 2024
Vizdiklar, C. Et Al. 2024. Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study. Vascular Pharmacology , vol.156 .
Vizdiklar, C., AYDIN, V., Tazegul, G., KAŞKAL, M., & AKICI, A., (2024). Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study. Vascular Pharmacology , vol.156.
Vizdiklar, Caner Et Al. "Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study," Vascular Pharmacology , vol.156, 2024
Vizdiklar, Caner Et Al. "Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study." Vascular Pharmacology , vol.156, 2024
Vizdiklar, C. Et Al. (2024) . "Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study." Vascular Pharmacology , vol.156.
@article{article, author={Caner Vizdiklar Et Al. }, title={Use of lipid-lowering drugs in restricted health access settings: Results from the Trends in Drug Utilization During COVID-19 Pandemic in Turkey (PANDUTI-TR) study}, journal={Vascular Pharmacology}, year=2024}